117 Kendrick Street
Tel: (718) 292-4200
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a clinical-stage biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. We are driven by the strength, tenacity and courage of those battling cancer – single-minded in our resolve to deliver new therapies that not only keep cancer at bay, but improve the lives of patients diagnosed with cancer. Because for us, it’s personal.
Our team is anchored by core values of character, urgency, respect and excellence. We pride ourselves in being an organization committed to diversity and inclusion in order to achieve and sustain excellence. At Verastem, we believe that empowering employees is what makes them truly care about the important work they do.
372 articles with Verastem Oncology
Verastem, Inc. to Present at Biotechnology Industry Organization (BIO) CEO and Leerink Swann and Company Conferences
Verastem, Inc. Release: Underwriters Exercise Over-Allotment Option for Verastem Initial Public Offering